1 |
33512466 |
10.1182/blood.2020010175 |
2021 |
OBF1 and Oct factors control the germinal center transcriptional program. |
POU2F2 |
2 |
34461601 |
10.1016/j.ebiom.2021.103559 |
2021 |
Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers. |
POU2F2 |
3 |
26993806 |
10.1073/pnas.1600557113 |
2016 |
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. |
POU2F2 |
4 |
27009953 |
10.1128/JVI.00239-16 |
2016 |
HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. |
POU2F2 |
5 |
25765478 |
10.1186/s12864-015-1303-0 |
2015 |
Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line. |
POU2F2 |
6 |
24344258 |
10.1073/pnas.1321704111 |
2014 |
Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. |
POU2F2 |
7 |
24435047 |
10.1182/blood-2013-05-500264 |
2014 |
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. |
POU2F2 |
8 |
23292937 |
10.1073/pnas.1205299110 |
2013 |
Genetic heterogeneity of diffuse large B-cell lymphoma. |
POU2F2 |
9 |
22346751 |
10.1371/journal.ppat.1002516 |
2012 |
The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. |
POU2F2 |
10 |
21424034 |
|
2011 |
B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. |
POU2F2 |
11 |
22158496 |
10.1700/989.10724 |
2011 |
Immunohistochemical expression of Mum-1, Oct-2 and Bcl-6 in systemic anaplastic large cell lymphomas. |
POU2F2 |
12 |
20141429 |
10.3109/10428191003592735 |
2010 |
OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. |
POU2F2 |
13 |
18695675 |
10.1038/onc.2008.286 |
2008 |
Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. |
POU2F2 |
14 |
16186795 |
10.1038/sj.onc.1209127 |
2006 |
Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression. |
POU2F2 |
15 |
15796964 |
10.1016/j.cancergencyto.2004.09.005 |
2005 |
Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma. |
POU2F2 |
16 |
14707079 |
10.4049/jimmunol.172.2.1054 |
2004 |
NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. |
POU2F2 |
17 |
15257313 |
10.1038/modpathol.3800227 |
2004 |
Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. |
POU2F2 |
18 |
12507907 |
10.1016/s0002-9440(10)63815-1 |
2003 |
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. |
POU2F2 |
19 |
12592383 |
10.1038/sj.onc.1206270 |
2003 |
Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. |
POU2F2 |
20 |
12598320 |
10.1016/S0002-9440(10)63882-5 |
2003 |
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. |
POU2F2 |
21 |
12647220 |
10.1007/s00428-002-0735-5 |
2003 |
Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. |
POU2F2 |
22 |
12848851 |
10.1046/j.0818-9641.2003.01172.x |
2003 |
Knockout B lymphoma cell lines as biochemical tools to explore multiple signalling pathways. |
POU2F2 |
23 |
14608905 |
10.1309/YCH8-DWUF-FQBK-GPVB |
2003 |
The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. |
POU2F2 |
24 |
14662861 |
10.4049/jimmunol.171.12.6589 |
2003 |
Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells. |
POU2F2 |
25 |
11929801 |
10.1182/blood.v99.8.3060 |
2002 |
Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. |
POU2F2 |
26 |
11154228 |
10.1182/blood.v97.2.496 |
2001 |
Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. |
POU2F2 |
27 |
11280769 |
|
2001 |
Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. |
POU2F2 |
28 |
11696441 |
10.1016/S0002-9440(10)63027-1 |
2001 |
The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. |
POU2F2 |
29 |
10727398 |
|
2000 |
Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability. |
POU2F2 |
30 |
9925930 |
10.1159/000015128 |
1998 |
Transcription factor effects on chromosome constitution of cell hybrids. |
POU2F2 |
31 |
8537118 |
10.1007/BF00186600 |
1996 |
The function of the octamer-binding site in the DRA promoter. |
POU2F2 |
32 |
8639794 |
|
1996 |
High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. |
POU2F2 |
33 |
7486513 |
10.1111/j.1749-6632.1995.tb55817.x |
1995 |
Role of Oct-2 in immunoglobulin gene silencing. |
POU2F2 |
34 |
7868225 |
10.1128/iai.63.3.1040-1046.1995 |
1995 |
Diphosphoryl lipid A from Rhodobacter sphaeroides transiently activates NF-kappa B but inhibits lipopolysaccharide induction of kappa light chain and Oct-2 in the B-cell lymphoma line 70Z/3. |
POU2F2 |
35 |
7600290 |
10.1016/1074-7613(94)90034-5 |
1994 |
Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids. |
POU2F2 |
36 |
7813434 |
10.1002/j.1460-2075.1994.tb06942.x |
1994 |
Transformation by homeobox genes can be mediated by selective transcriptional repression. |
POU2F2 |
37 |
8039828 |
10.1007/BF00167080 |
1994 |
Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3. |
POU2F2 |
38 |
8121549 |
|
1994 |
Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines. |
POU2F2 |
39 |
1937571 |
|
1991 |
Differentiation of human B-cell malignant lymphomas is independent of the octamer lymphoid specific binding factor (Oct-2). |
POU2F2 |
40 |
1689272 |
10.1007/BF00661216 |
1990 |
1.3E2, a variant of the B lymphoma 70Z/3, defective in activation of NF-kappa B and OTF-2. |
POU2F2 |